Piper Sandler Reiterates Overweight Rating on I-Mab (IMAB)

September 16, 2024 7:29 AM UTC Send to a Friend
Piper Sandler analyst Joseph Catanzaro reiterated an Overweight rating and $8.00 price target on I-Mab (NASDAQ: IMAB).The analyst commented, "At ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login